For the purposes of this Annex:
pharmaceutical products means any substance or combination of substances which may be administered to human beings with a view to making a medical diagnosis, to treating or preventing diseases or to restoring, correcting or modifying physiological functions or structures. Pharmaceutical products include, for example, chemical drugs, biologics/biologicals (vaccines, (anti)toxins, blood, blood components, blood-derived products), herbal drugs, radiopharmaceuticals, recombinant products, gene therapy products, cell therapy products and tissue engineered products;
medical device means any instrument, apparatus, appliance, material or other article, whether used alone or in combination, intended by the manufacturer to be used for human beings for medical purposes such as diagnosis, prevention, monitoring, treatment or alleviation of diseases [For greater clarity, medical device does not achieve its principal intended action in or on the human body by pharmacological, immunological or metabolic means, but may be assisted in its function by such means.]. Medical device includes software incorporated into the device by its manufacturer and necessary for the proper functioning of the device;
a Party’s health care authorities means entities that are part of or have been established by a Party to operate or administer its health care programmes, unless otherwise specified;
health care programmes operated by a Party means health care programmes in which the health care authorities of a Party make decisions regarding matters to which this Annex applies;
manufacturer refers to the legal right holder of the product in the respective Party’s territory;
a negative list is defined as a compilation of pharmaceutical products and medical devices that have been excluded from being prescribed and/or reimbursed under a Party’s public health care programme(s); and
a positive list is defined as an exhaustive compilation of pharmaceutical products and medical devices that can be prescribed and/or reimbursed under a Party’s public health care programme(s).
The definitions for pharmaceutical products and medical devices stated in paragraph 1 are without prejudice to each Party’s right to classify products as either pharmaceutical products or medical devices in its legislation.